Blocking noggin to enhance spinal fusion
Small Molecule Inhibition of Noggin to Induce Spinal Fusion
This study is exploring a new way to help your spine heal better after surgery by using a special material that helps encourage bone growth while reducing side effects, and it's showing good results in early tests with rabbits.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10847502 on NIH RePORTER |
What this research studies
This research investigates a new approach to improve spinal fusion by inhibiting a protein called noggin, which normally prevents bone formation. The team is developing a special scaffold that combines collagen with a coating to deliver a small molecule that blocks noggin's activity. By doing this, they aim to create an environment that allows for lower levels of another protein, BMP-2, to effectively induce bone growth without the side effects commonly associated with BMP-2 treatments. The research includes preliminary studies in rabbits that show promising results in enhancing bone formation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing spinal fusion surgery who may benefit from improved bone healing.
Not a fit: Patients who do not require spinal fusion or have contraindications for surgery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective treatments for spinal fusion, reducing complications associated with current therapies.
How similar studies have performed: Other research has shown success in using similar approaches to enhance bone formation, making this a promising area of investigation.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Boden, Scott D. — Emory University
- Study coordinator: Boden, Scott D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.